The estimated Net Worth of A Barry Rand is at least $9.53 millió dollars as of 10 March 2015. Mr. Rand owns over 8,870 units of Abbott Laboratories stock worth over $9,527,503 and over the last 21 years he sold ABT stock worth over $0. In addition, he makes $0 as Senior Vice President - CRM at Abbott Laboratories.
Randel has made over 9 trades of the Abbott Laboratories stock since 2005, according to the Form 4 filled with the SEC. Most recently he exercised 8,870 units of ABT stock worth $214,211 on 10 March 2015.
The largest trade he's ever made was exercising 10,336 units of Abbott Laboratories stock on 5 March 2014 worth over $309,150. On average, Randel trades about 888 units every 62 days since 2004. As of 10 March 2015 he still owns at least 81,711 units of Abbott Laboratories stock.
You can see the complete history of Mr. Rand stock trades at the bottom of the page.
Randel Woodgrift serves as Senior Vice President - CRM of the Company. He serve as Vice President, Global Operations, Cardiovascular and Neuromodulation. Vice President, Operations and R&D, Abbott Vascular.
Randel Woodgrift is 58, he's been the Senior Vice President - CRM of Abbott Laboratories since 2019. There are 21 older and 17 younger executives at Abbott Laboratories. The oldest executive at Abbott Laboratories is Samuel Scott, 75, who is the Independent Director.
Over the last 24 years, insiders at Abbott Laboratories have traded over $388,257,551 worth of Abbott Laboratories stock and bought 1,028,477 units worth $44,923,618 . The most active insiders traders include Miles D White, Richard A Gonzalez és Jeffrey M Leiden. On average, Abbott Laboratories executives and independent directors trade stock every 9 days with the average trade being worth of $4,003,344. The most recent stock trade was executed by John A. Jr. Mccoy on 1 September 2024, trading 27 units of ABT stock currently worth $3,100.
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States.
Abbott Laboratories executives and other stock owners filed with the SEC include: